コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e heparin-binding growth factors midkine and pleiotrophin.
2 evelopmentally regulated neurotrophic factor pleiotrophin.
3 cells expressed hepatocyte growth factor and pleiotrophin.
4 otentiated programmed cell death elicited by pleiotrophin.
5 rfering RNA-mediated knockdown of endogenous pleiotrophin.
6 ular matrix components and the growth factor pleiotrophin.
7 The identification of the novel biomarker pleiotrophin 151-166 demonstrates that our quantificatio
9 nase (ALK) as a tyrosine kinase receptor for pleiotrophin, a secreted growth factor that is highly ex
11 e cancer cells by inducing EMT and promoting pleiotrophin activity through the syndecan-3 pathway.
14 ealed the neurite outgrowth-promoting factor pleiotrophin, along with required binding partners SPARC
16 cord blood CD34(+)CDCD38(-)Lin(-) cells with pleiotrophin also substantially increased severe combine
19 any published reports focused on the role of pleiotrophin and its receptors, receptor protein tyrosin
22 The heparin-binding polypeptide homologs pleiotrophin and midkine are the only known members of a
28 was identified as a downstream target of the pleiotrophin/beta-catenin pathway by endogenous dlk1 exp
29 Treatment of mouse bone marrow HSCs with pleiotrophin caused a marked increase in long-term repop
33 re has a distant relationship to the midkine/pleiotrophin fold, particularly in the conservation of d
34 d to apparent homogeneity an 18 kDa protein, pleiotrophin, from the conditioned medium of a metanephr
37 iety of known UB branching morphogens (i.e., pleiotrophin, heregulin, FGF1 and GDNF) were found to ha
38 , WT1, BCL2, Homeobox protein A11, timeless, pleiotrophin, HGF, HNF3, BMP4, TGF-alpha, TGF-beta2, IGF
39 d resistance, mTOR in innate resistance, and pleiotrophin in both settings, suggesting their utility
49 nd progenitor cells in vivo, indicating that pleiotrophin is a regenerative growth factor for HSCs.
52 sociated with quiescence, and suppression of pleiotrophin is related to oncogenic transformation.
54 Additionally, we found that the cytokine pleiotrophin is sufficient to induce VEGFR2 expression o
55 ression is strongly enriched in the SVZ, and pleiotrophin knock down starkly reduced glioma invasion
58 ition of syndecan-3 expression inhibited the pleiotrophin-mediated cell migration and attachment thro
60 bition of RPTPbeta/zeta expression increased pleiotrophin-mediated migration and attachment through a
61 Pbeta/zeta knockdown initiates EMT, promotes pleiotrophin-mediated migration and attachment through S
63 stational ages 16-22 weeks, we asked whether pleiotrophin modulated the expansion of OPCs and, if so,
64 PZ was accompanied by that of its modulators pleiotrophin, NrCAM, tenascin, and the chondroitin sulfa
68 ithelial type II cells, we demonstrated that pleiotrophin promoted fetal type II cell proliferation a
71 hypoxia and that the addition of recombinant pleiotrophin promotes caspase-mediated genomic DNA fragm
72 7230]; P = 3.98 x 10(-)(1)(2)), the cytokine pleiotrophin (PTN [rs919581]; P = 5.38 x 10(-)(4)), the
75 ecently demonstrated that the growth factors pleiotrophin (PTN) and midkine (MK) are ligands for ALK
76 is inserted in the human growth factor gene pleiotrophin (PTN) between the 5' untranslated and the c
78 y reported that the angiogenic growth factor pleiotrophin (PTN) coaxes monocytes to assume the phenot
80 stitutively high levels of expression of the pleiotrophin (Ptn) gene are found in human breast cancer
81 element (HERV-E.PTN) into the growth factor pleiotrophin (PTN) gene generated a phylogenetically new
82 d 495 nucleotides is inserted into the human pleiotrophin (PTN) gene upstream of the open reading fra
94 In this study, we analyzed the growth factor pleiotrophin (PTN) that was originally described as a de
95 Herein, we report that TAMs secrete abundant pleiotrophin (PTN) to stimulate glioma stem cells (GSCs)
100 re, we found that systemic administration of pleiotrophin (PTN), a protein that is secreted by BM-der
101 ), brain-derived neurotrophic factor (BDNF), pleiotrophin (PTN), and NT-3 in asymmetrically guiding t
103 nase (ALK) and its ligand, the growth factor pleiotrophin (PTN), are highly expressed during the deve
104 pression of a heparin binding growth factor, pleiotrophin (Ptn), was found to be up-regulated in Pten
105 trating that LV-neural progenitors secrete a pleiotrophin (PTN)-containing complex, which attracts gl
111 amino acid secreted heparin-binding cytokine pleiotrophin (PTN, Ptn) stimulates both normal and patho
114 To investigate the mechanism through which pleiotrophin regulates tumor metastasis, we used two dif
115 argeting and demonstrated that this prevents pleiotrophin-stimulated phosphorylation of the anti-apop
118 eta/zeta (PTPRZ1) and its inhibitory ligand, pleiotrophin, suggesting the maintenance of an autocrine
119 d cell lines, and the molecular targeting of pleiotrophin to block its signaling in tumor cells has l
121 expression of the gene encoding the cytokine pleiotrophin was also found in Catnb(flox(ex3)/+);Amhr2(
122 bud morphogenesis during kidney development, pleiotrophin was found to localize to the basement membr
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。